Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Disturbances in emotion regulation among people who use opioids receiving methadone maintenance treatment (MMT) was reported in a few small studies.

Original research | 2024
About PWUD, Benzodiazepines, Clinical guidance, Evidence base, Illegal drugs, Mental health, Opioids, Stimulants, Substitution/OAT

Fentanyl and fentanyl analogues have disrupted the illegal drug supply through contamination of other substances (i.e., methamphetamine and cocaine) and replacement of heroin in illegal markets.

Original research | 2024
About PWUD, Barriers and enablers, Clinical guidance, Harm reduction, Illegal drugs, Injecting drugs, Substitution/OAT, Withdrawal

In parallel with rising mortality from drug toxicities, hospitalizations for infectious complications from substance use are increasing.

Case study | 2023
Barriers and enablers, Clinical guidance, Harm reduction, Hospitals, Equity, Injecting drugs, Illegal drugs, Peer/PWLLE program involvement, Substitution/OAT, Withdrawal, Stigma, Transitions in care/treatment

This is a report from the Office of the Provincial Health Officer in British Columbia highlighting the urgent need to expand access to alternatives to unregulated drugs during the toxic drug crisis

Report | 2024
About PWUD, Advocacy, Barriers and enablers, Clinical guidance, Equity, Evidence base, Harm reduction, Indigenous, Policy/Regulatory, Safer supply, Small/medium cities

To develop a clinical guideline for opioid withdrawal management in acute National Health Service (NHS) hospital trusts to be tested and evaluated as part of the iHOST (Improving Hospital Opioid Su

Original research | 2024
Barriers and enablers, Carries/take-home doses, Clinical guidance, Harm reduction, Hospitals, Opioids, Peer/PWLLE program involvement, Policy/Regulatory, Stigma, Substitution/OAT, Transitions in care/treatment, Withdrawal, Overdose

To provide guidance on evidence-based strategies for the treatment of stimulant use disorders (StUDs), stimulant intoxication, and stimulant withdrawal, as well as se

Guidelines | 2024
About PWUD, Clinical guidance, Hospitals, Illegal drugs, Return to use, Stimulants, Substitution/OAT, Transitions in care/treatment, Withdrawal, Wrap-around services
Commentary | 2022
About prescribers, Chronic pain, Clinical guidance, Hesitancy of prescribers , Outcomes, Withdrawal

To describe the implementation and short-term outcomes of an outpatient benzodiazepine taper protocol to treat benzodiazepine withdrawal in a substance use disorder bridge clinic.

Original research | 2024
About PWUD, Benzodiazepines, Clinical guidance, Mortality, Overdose, Return to use, Withdrawal, Wrap-around services

Several resources were developed collaboratively with service users, providers, research team members, and partners across Canada to mobilize the knowledge produced t

Other | 2024
About pharmacists, About prescribers, Barriers and enablers, Carries/take-home doses, Clinical guidance, Illegal drugs, Injecting drugs, Peer/PWLLE program involvement, Policy/Regulatory, Substitution/OAT, Withdrawal, Wrap-around services

This report is grounded in lived experience, and aims to provide a history of methadone therapy (MT) in the United States, to summarize the conference proceedings tha

Report | 2024
Advocacy, Barriers and enablers, Clinical guidance, Diversion, Equity, Overdose, Peer/PWLLE program involvement, Policy/Regulatory, Safer supply, Substitution/OAT

This webinar exists to kick off the research report (linked on webinar webpage) about opioid-related toxicity deaths in homeless shelters.

Archived webinar | 2024
About PWUD, Barriers and enablers, Clinical guidance, Harm reduction, Hospitals, Housing, Illegal drugs, Mortality, Overdose, Poverty, Social benefits, Social services

Involuntary care is permitted in BC for the treatment of substance use disorders, however there is insufficient understanding of the perspectives of people who use drugs (PWUD) on this approach, an

Original research | 2021
About PWUD, Barriers and enablers, Clinical guidance, Illegal drugs, Peer/PWLLE program involvement, Policy/Regulatory, Social services, Transitions in care/treatment, Withdrawal

This is a compilation of information and recommendations for the implementation and use of SROM in OAT. 

Guidelines | 2023
Substitution/OAT, Carries/take-home doses, Chronic pain, Clinical guidance, Transitions in care/treatment

This article provides a critical socio-historical analysis of heroin (opioid) regulation with a focus on Canadian federal and provincial policies in the province of B

Commentary | 2021
2SLGBTQI+, About PWUD, Advocacy, Illegal drugs, Clinical guidance, Legal system/law enforcement, Overdose, Policy/Regulatory
Guide or handbook | 2024
Clinical guidance, Illegal drugs
Commentary | 2024
Clinical guidance, About prescribers

One form of safe supply enlists clinicians to prescribe opioids so that people have access to drugs of known composition and strength.

Commentary | 2022
Safer supply, About prescribers, Harm reduction, Clinical guidance

This report presents a novel treatment protocol comprised of behavior-targeted and pharmacological components that aims to reduce the intensity and duration of methamphetamine intoxication and with

Original research | 2024
Stimulants, About PWUD, About prescribers, Withdrawal, Hospitals, Clinical guidance

This study aims to identify available addictive disorder screening tests whose feasibility has been evaluated in primary care.

Lit review | 2024
About prescribers, Clinical guidance
Guidelines | 2023
Youth, Withdrawal, Hospitals, Clinical guidance, About prescribers

Affiner votre recherche

Mots clés
Format
Région